PrabotulinumtoxinA-xvfs

prabotulinumtoxinA · Evolus, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PrabotulinumtoxinA-xvfs, covering 2024-09-04 to 2024-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar Lines [Phase 2]

See pricing